Perspective Therapeutics says FDA grants Fast Track status for [212Pb]PSV359 in FAP-positive solitary fibrous tumors
Bitget2026/10/08 10:16FDA granted Fast Track designation to Perspective Therapeutics’ investigational [212Pb]PSV359 for FAP-positive solitary fibrous tumors. Designation covers adults with locally advanced unresectable or metastatic disease, a rare cancer with limited treatment options. [212Pb]PSV359 is in a Phase 1/2a study in advanced FAP-positive solid tumors to support dose selection for Phase 2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perspective Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080616PRIMZONEFULLFEED9842019) on October 08, 2026, and is solely responsible for the information contained therein.
- FDA granted Fast Track designation to Perspective Therapeutics’ investigational [212Pb]PSV359 for FAP-positive solitary fibrous tumors.
- Designation covers adults with locally advanced unresectable or metastatic disease, a rare cancer with limited treatment options.
- [212Pb]PSV359 is in a Phase 1/2a study in advanced FAP-positive solid tumors to support dose selection for Phase 2.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December
Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.

Former Chainlink Product Marketing Director Michael Robinson joins Monad Foundation